SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-068186
Filing Date
2023-08-16
Accepted
2023-08-16 16:01:37
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea183614-6k_neurosense.htm   iXBRL 6-K 14699
2 PRESS RELEASE, DATED AUGUST 16, 2023 ea183614ex99-1_neurosense.htm EX-99.1 115014
3 CONDENSED INTERIM UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 ea183614ex99-2_neurosense.htm   iXBRL EX-99.2 281692
4 OPERATING AND FINANCIAL REVIEW AND PROSPECTS AS OF JUNE 30, 2023 ea183614ex99-3_neurosense.htm EX-99.3 85820
5 GRAPHIC ex99-1_001.jpg GRAPHIC 28228
  Complete submission text file 0001213900-23-068186.txt   2353884

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nrsn-20230630.xsd EX-101.SCH 47332
7 XBRL CALCULATION FILE nrsn-20230630_cal.xml EX-101.CAL 24976
8 XBRL DEFINITION FILE nrsn-20230630_def.xml EX-101.DEF 117751
9 XBRL LABEL FILE nrsn-20230630_lab.xml EX-101.LAB 267833
10 XBRL PRESENTATION FILE nrsn-20230630_pre.xml EX-101.PRE 122487
45 EXTRACTED XBRL INSTANCE DOCUMENT ea183614-6k_neurosense_htm.xml XML 218912
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41084 | Film No.: 231178171
SIC: 2834 Pharmaceutical Preparations